Importantly, decreased membranous and increased intracellular FGFRL1 levels correlated with adverse clinicopathological features of primary PCa, and the occurrence of nuclear staining was associated with a shortened time to BCR in PCa patients. This evidence concerns the gene FGFRL1 and posterior cortical atrophy.